Publications:

Supplemental & Archived Meningococcal Conjugate
ACIP Recommendations
as Published in Morbidity and Mortality Weekly Report (MMWR)
Advisory Committee on Immunization Practices (ACIP)

These MMWR publications were published in addition to the official CDC recommendations and serve as updates until the recommendations are revised and republished. These MMWRs contain important changes or supplemental recommendations that may include policy notes, changes or updates to recommendations, and notices to readers.

NOTE: As a general rule, if the official recommendations are dated later than the supplemental recommendations listed below, the official recommendations override the older items listed below.

For your convenience, the "Archived MMWR Publications" section can be used for historical and research purposes.

Supplemental Meningococcal Conjugate Recommendations

• October 14, 2011, Vol 60, #40
  Recommendation of the ACIP for Use of Quadrivalent Meningococcal Conjugate Vaccine (MenACWY-D) Among Children Aged 9 Through 23 Months at Increased Risk for Invasive Meningococcal Disease
  
• August 5, 2011, Vol 60, #3
  Licensure of a Meningococcal Conjugate Vaccine for Children Aged 2 Through 10 Years and Updated Booster Dose Guidance for Adolescents and Other Persons at Increased Risk for Meningococcal Disease -- Advisory Committee on Immunization Practices (ACIP), 2011
• March 12, 2010, Vol 59, #9
  Licensure of a Meningococcal Conjugate Vaccine (Menveo) and Guidance for Use -- Advisory Committee on Immunization Practices (ACIP), 2010
• September 25, 2009, Vol 58, # 37
  Updated Recommendation from the Advisory Committee on Immunization Practices (ACIP) for Revaccination of Persons at Prolonged Increased Risk for Meningococcal Disease
• May 2, 2008, Vol 57, #17
  Report from ACIP: Decision Not to Recommend Routine Vaccination of All Children Aged 2-10 Years with Quadrivalent Meningococcal Conjugate Vaccine (MCV4)
• December 7, 2007, Vol 56, #48
  Notice to Readers: Recommendation from ACIP for Use of Quadrivalent Meningococcal Conjugate Vaccine (MCV4) in Children Aged 2-10 Years at Increased Risk for Invasive Meningococcal Disease

Archived Meningococcal Conjugate Publications

• August 10, 2007, Vol 56, #31
  Notice to Readers: Revised Recommendations of the ACIP to Vaccinate All Persons Aged 11-18 Years with Meningococcal Conjugate Vaccine
• November 3, 2006, Vol 55, #43
  Notice to Readers: Improved Supply of Meningococcal Conjugate Vaccine, Recommendation to Resume Vaccination of Children Aged 11-12 Years
• September 22, 2006, Vol 55, #37
  Inadvertent Misadministration of Meningococcal Conjugate Vaccine -- United States, June-August 2005
• May 26, 2006, Vol 55, #20
  Notice to Readers: Limited Supply of Meningococcal Conjugate Vaccine, Recommendation to Defer Vaccination of Persons Aged 11-12 Years
• Feb 14, 1997, Vol 46, #RR-5
  Control and Prevention of Serogroup C Meningococcal Disease: Evaluation and Management of Suspected Outbreaks: Recommendations of the ACIP

 Return to ACIP-related MMWR page

• Email this page
• Printer-friendly version

• Help
• Glossary / Acronyms
• Site Map